Rare lephants
Screener

Crescent Biopharma, Inc.

CBIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 15, 2026 8-K
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
S-8 Sep 18, 2026 S-8
144 Sep 17, 2026
144 Sep 17, 2026
144 Sep 16, 2026
144 Sep 16, 2026
SCHEDULE 13G/A Aug 14, 2026
EFFECT Jul 31, 2026
POS AM Jul 30, 2026 POS AM
424B3 Jul 30, 2026 424B3
10-Q Jul 30, 2026 10-Q
8-K Jul 30, 2026 8-K
SCHEDULE 13D/A Jul 20, 2026
4 Jul 20, 2026 OWNERSHIP DOCUMENT
8-K Jul 15, 2026 8-K
424B5 Jul 15, 2026 424B5
8-K Jul 14, 2026 8-K
424B5 Jul 14, 2026 424B5
← Newer Page 1 of 27 · 675 filings Older →